OgCelix: Driving Organoid Research Forward

OgCelix provides a comprehensive portfolio of organoid products designed to advance both basic and translational research. Our 3D-ready organoid models, derived from healthy tissue, Induced Pluripotent Stem Cells (iPSCs), patient samples, and selected animal sources, covering a wide range of organs including liver, lung, brain, colon, pancreas, and breast. These models recapitulate key aspects of native tissue architecture,maintain key genomic features over passages under defined conditions, and patient-derived models retain disease-relevant phenotype, making them powerful systems for studying human development, disease mechanisms, drug response, and precision medicine applications.

To support reliable organoid establishment and long-term growth, we supply a full range of media and reagents, including culture media, basement membranes matrix, growth factors, and culture plates, all support robust expansion and controlled differentiation. Complementing these are organoid-validated antibodies antibodies targeting key lineage, immune, and tumor-associated markers, rigorously validated across applications such as IHC, IF, WB, and flow cytometry to provide high-confidence results.

Beyond models and reagents, OgCelix also delivers a range of services that broaden the possibilities of organoid research. All our products and services are supported by stringent quality control measures to ensure consistency, reliability, and scientific rigor across every stage of research.

With a portfolio that unites organoid models, culture systems, antibodies, and advanced services, OgCelix equips researchers with the tools and confidence to generate reproducible, clinically relevant insights and to accelerate the journey from discovery to therapeutic innovation.

Product Features 

  • Diverse Origins 

    Organoid models derived from ASCs, iPSCs, or tissues, including both healthy and disease-specific samples.

  • Physiological Relevance

    Organoids maintain native tissue architecture and functional properties that closely mimic in vivo conditions.

  • Long-Term Stability

    Demonstrated genetic and phenotypic stability across extended culture periods, ensuring reproducibility.

Showing all 378 results

  • Human iPSC-derived Cardiac Organoid

    3D Ready Organoid |C-037

    Human iPSC-derived Cardiac Organoid

    Organism

    Human

    Tissue

    Cardiac

    Disease

    Normal

  • Human iPSC-Derived Lung Organoid

    3D Ready Organoid |C-038

    Human iPSC-Derived Lung Organoid

    Organism

    Human

    Tissue

    Lung

    Disease

    Normal

  • Human Lung organoid

    3D Ready Organoid |C-039

    Human Lung organoid

    Organism

    Human

    Tissue

    Lung

    Disease

    Normal

  • Human Patient-Derived Lung Cancer Organoid

    3D Ready Organoid |C-040

    Human Patient-Derived Lung Cancer Organoid

    Organism

    Human

    Tissue

    Lung

    Disease

    Cancer

  • Mouse Lung Organoid

    3D Ready Organoid |C-041

    Mouse Lung Organoid

    Organism

    Mouse

    Tissue

    Lung

    Disease

    Normal

  • Ovine Lung Organoid

    3D Ready Organoid |C-042

    Ovine Lung Organoid

    Organism

    Ovine

    Tissue

    Lung

    Disease

    Normal

  • Porcine Lung Organoid

    3D Ready Organoid |C-043

    Porcine Lung Organoid

    Organism

    Porcine

    Tissue

    Lung

    Disease

    Normal

  • Bovine Lung Organoid

    3D Ready Organoid |C-044

    Bovine Lung Organoid

    Organism

    Bovine

    Tissue

    Lung

    Disease

    Normal

  • Human Primary Breast Cancer Organoid

    3D Ready Organoid |C-045

    Human Primary Breast Cancer Organoid

    Organism

    Human

    Tissue

    Breast

    Disease

    Cancer

Whether you're exploring disease mechanisms or screening novel therapeutics, OgCelix is your trusted partner.

Let's build the future of translational research together.

Let's Talk Now

Whether you're exploring disease mechanisms or screening novel therapeutics, OgCelix is your trusted partner.

Let's build the future of translational research together.

Let's Talk Now